Stay updated on Efgartigimod in Post-COVID-19 POTS Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod in Post-COVID-19 POTS Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-20T08:29:43.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The error page footer now shows revision v3.7.1 instead of v3.7.0; the page remains a 403 Forbidden response.
    Difference
    0.2%
    Check dated 2026-10-13T10:32:20.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the study record content; this indicates an access-related issue that blocks viewing the study details.
    Difference
    19%
    Check dated 2026-09-22T12:28:52.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous v3.6.5. This indicates a small software/content update to the page.
    Difference
    0.1%
    Check dated 2026-08-31T23:49:35.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page's revision indicator was updated to v3.6.5, replacing the previous v3.6.4, indicating a small release/maintenance update.
    Difference
    0.0%
    Check dated 2026-08-10T13:21:38.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3. This indicates a backend or tooling update rather than a change to the visible study details.
    Difference
    0.0%
    Check dated 2026-07-27T05:59:30.000Z thumbnail image

Stay in the know with updates to Efgartigimod in Post-COVID-19 POTS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.